DNDN – The Provenge HR at the interim look is 1.25 (0.80 when expressed as a reciprocal) and the trial will proceed to the final analysis at 304 events. <a href="http://biz.yahoo.com/prnews/081006/aqm055.html" target="_blank">http://biz.yahoo.com/prnews/081006/aqm055.html</a> I seem to recall there was someone who stated that the true underlying HR of Provenge in this patient pool was about 1.25. The evidence is in <a href='read_msg.asp?message_id=28441649'>#msg-28441649</a> :- )